BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 26470718)

  • 1. The role of methotrexate in psoriatic arthritis: what is the evidence?
    Ianculescu I; Weisman MH
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S94-7. PubMed ID: 26470718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New GRAPPA and EULAR recommendations for the management of psoriatic arthritis.
    Coates LC; Gossec L; Ramiro S; Mease P; van der Heijde D; Smolen JS; Ritchlin C; Kavanaugh A
    Rheumatology (Oxford); 2017 Aug; 56(8):1251-1253. PubMed ID: 28077693
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of methotrexate in patients with psoriatic arthritis.
    Ceponis A; Kavanaugh A
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S132-7. PubMed ID: 21044447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriatic arthritis, methotrexate and the liver--are rheumatologists putting their patients at risk?
    Lindsay K; Gough A
    Rheumatology (Oxford); 2008 Jul; 47(7):939-41. PubMed ID: 18474510
    [No Abstract]   [Full Text] [Related]  

  • 5. Psoriatic Arthritis Registries.
    Sarzi-Puttini P; Varisco V; Ditto MC; Benucci M; Atzeni F
    J Rheumatol Suppl; 2015 Nov; 93():30-2. PubMed ID: 26523052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate (MTX) underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis?
    Pincus T; Bergman MJ; Yazici Y
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S82-93. PubMed ID: 26472658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Agents other than Tumor Necrosis Factor Blockers in the Treatment of Psoriatic Arthritis.
    Atzeni F; Costa L; Caso F; Scarpa R; Sarzi-Puttini P
    J Rheumatol Suppl; 2015 Nov; 93():79-81. PubMed ID: 26523064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for the therapeutics of methotrexate in rheumatoid arthritis.
    Murphy G; Coughlan R; Devlin J; FitzGerald O; McCarthy G
    Ir Med J; 2009 Jun; 102(6):170-2. PubMed ID: 19722351
    [No Abstract]   [Full Text] [Related]  

  • 9. [Psoriatic arthritis (PsA)].
    Behrens F
    Krankenpfl J; 2004; 42(5-6):180. PubMed ID: 15527240
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
    Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
    Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-modifying Antirheumatic Drugs (DMARD) and Combination Therapy of Conventional DMARD in Patients with Spondyloarthritis and Psoriatic Arthritis with Axial Involvement.
    Simone D; Nowik M; Gremese E; Ferraccioli GF
    J Rheumatol Suppl; 2015 Nov; 93():65-9. PubMed ID: 26523061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriatic arthritis for the dermatologist.
    Tintle SJ; Gottlieb AB
    Dermatol Clin; 2015 Jan; 33(1):127-48. PubMed ID: 25412788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Treatment Patterns in Patients with Psoriatic Arthritis Initiating Biologic and Nonbiologic Therapy in a Clinical Registry.
    Mease PJ; Lesperance T; Liu M; Collier DH; Mason M; Deveikis S; Accortt NA
    J Rheumatol; 2017 Feb; 44(2):184-192. PubMed ID: 28089969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriatic Disease: Update on Traditional Disease-modifying Antirheumatic Drugs.
    Marchesoni A; Lubrano E; Cauli A; Ricci M; Manara M
    J Rheumatol Suppl; 2015 Nov; 93():61-4. PubMed ID: 26523060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study.
    Heiberg MS; Kaufmann C; Rødevand E; Mikkelsen K; Koldingsnes W; Mowinckel P; Kvien TK
    Ann Rheum Dis; 2007 Aug; 66(8):1038-42. PubMed ID: 17213251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inflammatory rheumatic diseases].
    Kellner H
    MMW Fortschr Med; 2009 Apr; 151(14):67-70; quiz 71. PubMed ID: 19504844
    [No Abstract]   [Full Text] [Related]  

  • 17. Do Biologic-treated Psoriatic Arthritis Patients with Spondylitis Respond Differently with or without Concomitant Methotrexate from Patients without Spondylitis?
    Mease PJ
    J Rheumatol; 2016 Mar; 43(3):471-3. PubMed ID: 26932987
    [No Abstract]   [Full Text] [Related]  

  • 18. Conventional therapy of psoriatic arthritis: evidence-based review.
    McHugh NJ; Soriano ER
    Reumatismo; 2007; 59 Suppl 1():81-4. PubMed ID: 17828352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spondyloarthritis: Is methotrexate effective in psoriatic arthritis?
    Mease PJ
    Nat Rev Rheumatol; 2012 May; 8(5):251-2. PubMed ID: 22549279
    [No Abstract]   [Full Text] [Related]  

  • 20. Disease-modifying antirheumatic drug therapy for psoriatic arthritis.
    Salvarani C; Cantini F; Olivieri I
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S71-5. PubMed ID: 12463452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.